Methylphenidate and Central Precocious Puberty: A Probable Side Effect among Seven Children with the Attention Deficit Hyperactivity Disorder

Methylphenidate (MPH) is the most preferred drug for treatment of the attention deficit hyperactivity disorder (ADHD). Here, we aimed to discuss the possible effects and mechanisms of MPH on precocious puberty (PP) via a case series with seven children who had normal body mass index. In this case se...

Descripción completa

Detalles Bibliográficos
Autores principales: Ergür, Ayça Törel, Gül, Hesna, Gül, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705097/
https://www.ncbi.nlm.nih.gov/pubmed/31352713
http://dx.doi.org/10.9758/cpn.2019.17.3.446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705097/
https://www.ncbi.nlm.nih.gov/pubmed/31352713
http://dx.doi.org/10.9758/cpn.2019.17.3.446

Ejemplares similares